Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin.

about

Equilibrative nucleoside transporter 1 expression in primary human hepatocytes is highly variable and determines uptake of ribavirin.

Item

http://www.wikidata.org/entity/Q38707179

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Equilibrative nucleoside trans ...... etermines uptake of ribavirin.

@en

type

Item

label

Equilibrative nucleoside trans ...... etermines uptake of ribavirin.

@en

prefLabel

Equilibrative nucleoside trans ...... etermines uptake of ribavirin.

@en

P1476

Equilibrative nucleoside trans ...... determines uptake of ribavirin

@en

P2093

Ameer A Memon

http://www.w3.org/2001/XMLSchema#string

Kanwal Baloch

http://www.w3.org/2001/XMLSchema#string

Laura Dexter

http://www.w3.org/2001/XMLSchema#string

Liqiong Chen

http://www.w3.org/2001/XMLSchema#string

Mohammad Ilyas

http://www.w3.org/2001/XMLSchema#string

P2860

hENT1 expression is predictive of gemcitabine outcome in pancreatic cancer: a systematic review

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

Sofosbuvir for previously untreated chronic hepatitis C infection

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Recent advances in human hepatocyte culture systems.

Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs.

Human equilibrative nucleoside transporter-3 (hENT3) spectrum disorder mutations impair nucleoside transport, protein localization, and stability.

P304

2-10

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/2040206616686894

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

William L. Irving

Brian J Thomson

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28417642

http://www.w3.org/2001/XMLSchema#string

P932

5890492

http://www.w3.org/2001/XMLSchema#string